Ignite Creation Date:
2024-05-06 @ 7:34 PM
Last Modification Date:
2024-10-26 @ 3:09 PM
Study NCT ID:
NCT06052930
Status:
COMPLETED
Last Update Posted:
2023-09-25
First Post:
2023-08-14
Brief Title:
Immersive Virtual Reality for the Non-pharmacological Management of Parkinsons Disease
Sponsor:
Campus Neurológico Sénior
Organization:
Campus Neurológico Sénior
Study Overview
Official Title:
Immersive Virtual Reality for the Non-pharmacological Management of Parkinsons Disease
Status:
COMPLETED
Status Verified Date:
2023-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this clinical trial is to evaluate the feasibility safety and efficacy of an immersive virtual reality IVR exergaming using a head-mounted display in Parkinsons disease symptomatic control
This is a parallel-group single-blinded randomized controlled trial The intervention group perform 12 weeks of physiotherapy and IVR whereas the control group have 6 weeks of physiotherapy only followed by 6 weeks of physiotherapy and IVR The primary outcome is the symptomatic effect of the intervention as measured by the change from baseline in Time Up and Go TUG test with cognitive dual-task TUG cognitive
This is a parallel-group single-blinded randomized controlled trial The intervention group perform 12 weeks of physiotherapy and IVR whereas the control group have 6 weeks of physiotherapy only followed by 6 weeks of physiotherapy and IVR The primary outcome is the symptomatic effect of the intervention as measured by the change from baseline in Time Up and Go TUG test with cognitive dual-task TUG cognitive
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None